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Background: Pancreatic paragangliomas are rare tumors, with only 16 reported cases to date. One of these cases
demonstrates metastasis to lymph node, while another case was functional, however, none of these cases showed
malignant and large, pancreatic paraganglioma with marked invasion. Also another unique feature was the age of
our patient compared to the average reported ages in published literature (42–85 years).
Case presentation: A 19-year-old woman presented with a one-year history of intermittent abdominal pain.
Physical examination showed a palpable mass in the right upper abdomen, but initial laboratory results were within
normal ranges; tumor markers (CEA, AFP, and CA19-9) were negative. An abdominal and pelvic computed
tomography (CT) scan showed a well-defined retroperitoneal para-aortic mass. The CT scan revealed that the
surrounding lymph nodes were not enlarged, but the liver showed evidence of parenchymal infiltration.
Intraoperatively, a large, firm tumor originating from the head of pancreas was found pushing on the caudate
hepatic lobe and the inferior vena cava (IVC). The tumor was resected through a pancreaticoduodenectomy,
involving segment VI of the liver and a small segment of the IVC. The blood pressure spiked (>220 mm Hg) when
the tumor was manipulated during the operation. The final pathology report showed a 9-cm tumor with
lymphovascular invasions; immunohistochemistry was positive for synaptophysin and chromogranin. All resection
margins were negative and 1/15 lymph nodes was positive for metastasis. Post-operative recovery was
unremarkable. One month after discharge, the patient was re-admitted with abdominal pain and found to have an
abdominal collection at the resection site, which was drained under CT guidance. She received a therapeutic dose
of I131-metaiodobenzylguanidine (MIBG). Follow-ups showed the absence of recurrence, and she has remained
disease free.
Conclusion: This patient was an extraordinary example of a rare tumor. Even more remarkable was that the tumor
was malignant with lymph node invasion. To our knowledge, a case similar to that presented here has not been
previously reported in the literature.
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Pancreatic paragangiliomaBackground
Paragangliomas are rare tumors of neural crest origin,
with a malignancy rate of approximately 10% and a 5-year
survival rate of <50%. However, in the absence of metasta-
sis, the tumors are considered benign [1,2]. The average
age reported in the literature for the detection of extra-* Correspondence: Jiffrybilal@hotmail.com
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reproduction in any medium, provided the oradrenal pancreatic paragangliomas is 67 years (range, 42–
85 years) [1]. Primary paragangliomas of the pancreas are
extremely rare, with only 16 cases having been reported in
the literature [3,4]. In the previously reported 16 primary
pancreatic paragangliomas, there was only one case that
was considered malignant with lymph node metastasis
and one case that showed hormonal activity [1,5]. In this
report, we present a malignant pancreatic paraganglioma
in a 19-year-old woman.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 19-year-old woman presented in March 2010 with
vague, recurrent upper abdominal pain. The pain had
been occurring for approximately one year and had in-
creased in frequency and severity. A physical examin-
ation revealed the presence of a large, palpable firm
mass, which was slightly mobile, with an irregular out-
line, in the right upper abdomen. There were no other
remarkable findings. An initial laboratory investigation
returned results that were within normal ranges, while
the tumor markers CEA, AFP, and CA19-9 were notFigure 1 A computed tomography scan demonstrating a large, well d
and ancinate process with marked enhancement in the arterial phase. E-F:
anteromedial to the right kidney, abutting the fundus of the gall bladder, aelevated. An abdomino-pelvic computed tomography
(CT) scan (Figure 1) showed a well-defined kidney-
shaped retroperitoneal para-aortic mass. The mass mea-
sured 9 cm × 5 cm × 9.5 cm and showed peripheral en-
hancement after injection of an intravenous contrast
agent with a relatively central hypodense pattern and
abundant vascularity. The lesion originated from the
posterior aspect of the head and neck of the pancreas.
Figures 1A and B show the mass in the pancreatic head
and ancinate process with marked enhancement in the
arterial phase, and wash out in the venous phase. Theefined pancreatic mass. A-D shows the mass in the pancreatic head
The lesion was anterior to the aorta and inferior vena cava,
nd reaching the level of porta hepatis.
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(IVC) and was anteromedial to the right kidney, abutting
the fundus of the gall bladder, and reaching the level of
porta hepatis (Figure 1C-F). There was evidence of par-
enchymal infiltration into the liver, but enlarged lymph
nodes were not detected by CT. Based on these findings,
a differential diagnosis of sarcoma was made.
Intraoperatively, a large, firm tumor, originating from
the head of pancreas, was found pushing against the caud-
ate hepatic lobe and IVC. Multiple reactive lymph nodes
were also identified in frozen sections. An open biopsy
showed that the mass was a neuroendocrine tumor. The
tumor was resected using a pancreaticodudenectomy
(Whipple procedure) and it included segment VI of the
liver and a small segment of the IVC. During the oper-
ation, the patient’s blood pressure spiked (>220 mm Hg)
when the tumor was manipulated. The increase in blood
pressure was not transient and it could only be controlled
through a continuous infusion of a combination of alphaFigure 2 Pathology slides of the resected specimen with different sta
pancreas demonstrating the classical features of paragangiloma. (B) Lymph
chromogranin. (D) S-100 immunohistochemical stain highlighting the suste
showing that the tumor is pushing onto the boundaries of the liver. (F) He
infiltration into the pancreatic tissue.and beta blockers, in addition to nitroglycerine, until the
tumor was resected.
The final pathology report described a 9-cm tumor,
composed of well-defined nests of cuboidal cells sepa-
rated by vascular fibrous septa, having a classic zellballen
appearance, with lymphovascular invasion; immunohis-
tochemistry was positive for synaptophysin and chro-
mogranin. All the resection margins were negative, and
only one of the 15 lymph nodes showing evidence of
metastasis (Figure 2A-D). Histological staining showed
that the tumor completely infiltrates the pancreas; how-
ever, it is only pushing into the boundaries of the liver
tissue (Figure 2E-F).
Although the patient’s post-operative recovery was
unremarkable, she was re-admitted with recurrent ab-
dominal pain one month after being discharged. Fur-
ther examination revealed an abdominal collection at
the site of the resection. The site was drained under CT
guidance and the patient received a therapeutic dose ofins and sites. (A) Hematoxylin and eosin stained section of the
node demonstrating metastasis. (C) Diffuse cytoplasmic positivity for
nticular cells. (E) Hematoxylin and eosin stained section of the liver
matoxylin and eosin stained section of the pancreas showing an
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body scan revealed the absence of other associated neuro-
endocrine tumors and no evidence of multicentricity.
Repeated follow-up MIBG scans were done, without
evidence of recurrence. The patient has been disease
free for >36 months.
Conclusion
We report here a case of pancreatic paraganglioma, was
identified through CT scan and histological evidences.
We ruled out that the tumor was retroperitoneal because
it was not attached to any structure and it fully mobilized
with the head of the pancreas on kocherization, as a single
mass. In addition, pathological findings showed that the
tumor was very infiltrative and involved the entire pancre-
atic tissue. On the contrary, the tumor did not seem to
originate from the liver because it covered only a small
part of the liver as seen on the CT scan. It did not infil-
trate into the liver tissue and was only pushing onto the
boundary of the liver as seen on the pathology slide, which
most likely means that it did not originate from the liver.
Pancreatic paragangliomas are extremely rare, with
only 16 cases having been reported in the literature.
Whether this tumor type is an extension of a retroperi-
toneal tumor of true visceral origin, derived from ectopic
paraganglia, remains unknown [1,2]. The mean age of
the 16 patients with pancreatic paragangliomas, reported
in the literature, was 67 years (range, 42–85 years). Of
those patients, 11 were women [1]. The patient in the
present case was a woman and the youngest individual
to have been diagnosed with pancreatic paraganglioma.
Preoperative diagnosis of pancreatic paraganglioma is
difficult unless the tumor is functional. However, pancre-
atic paragangliomas are generally non-functional as
evidenced by the fact that only 1 of the previous 16 cases
showed hormonal secretion [5]. Our patient presented
with a painful upper abdominal mass but she was not
hypertensive. However, her blood pressure spiked during
the operation when the tumor was manipulated and was
only controlled through a continuous infusion of alpha
and beta blockers and nitroglycerine, raising the possibil-
ity of a functional tumor. Unfortunately, since we did
not suspect the possibility of a functional tumor until we
observed the marked increase in blood pressure at the
time of resection and tumor manipulation, we did not
measure the hormonal levels and we cannot be certain
of the functional nature of the tumor.
The CT findings of pancreatic paragangliomas are dif-
ferent from those of pancreatic carcinomas. The latter
appear as poorly enhanced masses with dilation of the
bile and pancreatic ducts, as well as retroperitoneal in-
volvement. In contrast, pancreatic paragangliomas, even
when located at the head of pancreas, are not usually as-
sociated with biliary duct dilation and the patients arenot usually jaundiced, which aids in differentiating pan-
creatic paraganglioma from pancreatic carcinoma [6,7].
In the present case, the patient was not jaundiced and
her abdomino-pelvic CT scan showed a well-defined,
hypervascular pancreatic mass with evidence of hepatic
parenchymal infiltration, but a normal biliary tree. Hyper-
vascularity is another common feature of paragangliomas
of the pancreas and other sites [6].
Pancreatic paragangliomas have been reported in mul-
tiple locations throughout the pancreas, including the
head (about two thirds of the reported cases), body, and
tail [1,2,8]. In our study, the tumor originated from the
head of pancreas and was large and firm. The present
tumor, measuring 9 cm, is the largest known to have
been reported, with typical tumor sizes ranging from 2–
6 cm [1,4,8,9].
The pathology of these tumors is based on careful gross
examinations of the specimens and histopathological stud-
ies based on hematoxylin-eosin sections. In addition, im-
munohistochemistry usually reveals these tumors to be
positive for synaptophysin and chromogranin [10,11], as
in the present case. Pheochromocytomas and extra-
adrenal paragangliomas have unpredictable behavior and
often metastasize late. Therefore, these tumors should
never be considered malignant unless there is docu-
mented metastasis to the lymph nodes or other distant
sites. However, extensive local invasion should be docu-
mented as it is commonly correlated with the metastatic
potential of the tumor [11]. Mitotic activity, vascular inva-
sion, and necrosis are histological features that are sug-
gestive, but not diagnostic, of malignant behavior [10].
The pathologist has to retain a high index of suspicion to
avoid interpreting separate primary tumors as lymph
nodes [11].
Kimura et al. introduced a scoring system to predict
the prognosis of pheochromocytomas and other extra-
adrenal sympathetic paragangliomas. This scoring system
depends on the tumor characteristics, including the tumor
pattern (large, irregular nests, pseudo-rosettes), increased
cellularity vascular invasion, coagulation necrosis, high
proliferation index, and the type of catecholamine secre-
tion [12]. The scores were stratified into well, moderate,
and poorly differentiated categories and the risk of metas-
tasis was found to increase when the tumor became less
differentiated. In the present case, the final pathology re-
port described a tumor with lymphovascular invasion. Im-
munohistochemistry revealed that the tumor was positive
for the presence of synaptophysin and chromogranin with
one metastatic lymph node. This positive lymph node and
the lymphovascular invasion provided clear evidence of
the malignant nature of the tumor, making the present
case the second malignant case reported in the literature.
The first was reported by Higa and Kapur where there
was one positive lymph node out of 44 studied specimens
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node or distant metastases. Similarly, none of the other
case follow-ups described the development of metastases
in high risk patients.
Although most paragangliomas are solitary and typically
arise sporadically, they can be multicentric or hereditary.
Therefore, a screen for additional tumors is necessary
since they may be considered as part of multiple endo-
crine neoplasms [1,2,13]. In addition, the possibility of ma-
lignant transformation of paragangliomas makes surgical
excision the treatment of choice, and aggressive surgery is
mandatory to obtain disease-free survival [13]. For pancre-
atic lesions, pancreaticoduodenectomy is recommended
for tumors of the pancreatic head; for other locations,
distal or even total pancreatectomy may be indicated,
according to the tumor extension [13,14]. In this case, a
pancreaticoduodenectomy was performed and the patient
had an uneventful postoperative course. Postoperative ra-
diation therapy has also been advocated in cases proven to
be malignant [15]. Therapy with radionucleotides may be
used for tumors exhibiting uptake on diagnostic scans,
with I131-MIBG radiotherapy being the treatment of
choice. Chemotherapy is reserved for more advanced dis-
ease stages. Even in advanced cases, recent genetic studies
have suggested that the use of targeted therapy may be
useful, but additional validation is still required [15]. In
the present case, the patient received a therapeutic dose of
I131-MIBG one month after the operation, and remains
disease-free after more than 36 months.
In conclusion, pancreatic paragangliomas are rare tu-
mors, with only 16 cases reported to date. The patient in
the present case was the youngest among the reported
cases and the tumor was the largest reported. In addition,
this is the second case with lymph node metastasis ever to
be reported.
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